What are the Tennessee criteria for diagnosing and managing HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tennessee Criteria for HELLP Syndrome

The Tennessee Classification System diagnoses HELLP syndrome by three mandatory components: hemolysis with LDH >600 U/L, elevated liver enzymes with AST ≥70 U/L, and thrombocytopenia with platelets <100,000/mm³. 1

Diagnostic Criteria

The Tennessee system requires all three of the following laboratory findings to establish the diagnosis:

  • Hemolysis: LDH >600 U/L, which serves as a dual marker reflecting both the extent of hemolysis and hepatic dysfunction 2, 1
  • Elevated liver enzymes: AST ≥70 U/L (ALT is also typically elevated) 1
  • Low platelet count: Platelets <100,000/mm³, which ACOG identifies as the threshold indicating severe thrombocytopenia with significant maternal risk 3, 2

Additional confirmatory findings include:

  • Microangiopathic hemolytic anemia confirmed by peripheral blood smear showing schistocytes from endothelial damage with fibrin deposition 2
  • Elevated total bilirubin as part of the hemolysis picture 2

Key Distinction from Mississippi Classification

While the Tennessee system provides a binary diagnosis (HELLP present or absent), the Mississippi Triple-class system further stratifies HELLP severity by nadir platelet counts into three classes, with Class 1 defined as platelets ≤50,000/mm³ carrying the highest risk of hemorrhagic complications 1, 4

Clinical Context and Timing

  • HELLP typically develops in the third trimester (70% of cases occur before delivery, predominantly between 27-37 weeks gestation) in patients with severe preeclampsia 1, 5
  • Approximately 30% of cases occur or worsen postpartum within 48-72 hours after delivery, with laboratory abnormalities peaking at 24 hours postpartum 2, 6
  • The syndrome may present as complete (meeting all three criteria) or incomplete (meeting only some criteria) 1, 5

Critical Clinical Correlations

The degree of thrombocytopenia directly correlates with severity of liver dysfunction and predicts adverse maternal outcomes. 3, 2

  • Platelet counts ≤40,000/mm³ represent the threshold most predictive of postpartum hemorrhagic complications 4
  • Right upper quadrant or epigastric pain (present in 65% of symptomatic patients) should immediately trigger abdominal imaging to rule out subcapsular hematoma or hepatic rupture 3, 2

Essential Laboratory Monitoring

Beyond the diagnostic triad, obtain the following for complete assessment and surgical planning:

  • Coagulation studies: PT, PTT, fibrinogen, fibrin degradation products 2
  • Renal function: serum creatinine, urea, uric acid 2
  • Complete blood count with peripheral smear 2
  • Chest X-ray to exclude pulmonary edema 2

Common Pitfall

Do not delay delivery waiting for laboratory values to normalize—HELLP syndrome only resolves after delivery, and maternal mortality reaches 3.4% with delayed intervention. 3 The Tennessee criteria establish diagnosis to trigger immediate management, not to guide conservative observation.

References

Research

The HELLP syndrome: clinical issues and management. A Review.

BMC pregnancy and childbirth, 2009

Guideline

HELLP Syndrome Diagnostic Criteria and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The HELLP syndrome.

Acta clinica Belgica, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.